Teva announces launch of generic Epzicom® tablets in the U.S.
Teva announced the launch of a generic equivalent of Epzicom®1 (abacavir and lamivudine) tablets, 600 mg/300 mg, in the U.S. Abacavir and lamivudine tablets are indicated in combination with other antiretroviral agents for treatment of HIV-1 infection. September 28, 2016